AKT1 and neoplasm: It has been reported that the constitutive phosphorylation of Akt in cancer cells activates different targets for tumor development as a pathway to chemoresistance in cancer, and the PI3K/Akt/mTOR pathway inhibition has been associated with high survival rates in different types of cancer.